వెతకండి (వార్తలు)

Neutrolis Announces New England Journal Of Medicine Publication Demonstrating First Clinical Evidence For NET-Degrading Therapy In Severe, Treatment-Refractory Systemic Lupus Erythematosus (SLE) Caused By DNASE1L3 Deficiency

english top health

(MENAFN - GlobeNewsWire - Nasdaq) Treatment with investigational DNASE1L3 analog NTR-441, which degrades neutrophil extracellular traps (NETs), resulted in rapid clinical improvement in a patient ...
2026-07-15 17:03:03